We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Anisa Shaker MD

Anisa Shaker MD

Associate Professor of Medicine, Division of Gastroenterology and Hepatology, Keck School of Medicine, University of Southern California, Los Angeles, California

Dr. Shaker is an Associate Professor of Medicine and Director of the Swallowing and Esophageal Disorders Center in the Division of Gastroenterology and Hepatology at the Keck School of Medicine of USC.  After earning her medical degree from the Medical College of Wisconsin, she completed her internship and residency at Brown University-Rhode Island Hospital, followed by a T32 Gastroenterology Fellowship at Washington University School of Medicine in St. Louis. As a R01 funded NIH investigator, her research program is focused on understanding the cellular and molecular mechanisms of esophageal injury, repair, and inflammation. A dedicated clinician and esophageal biologist/physiologist, she also has an active and multi-disciplinary clinical practice focused on the care of patients with swallowing and esophageal disorders.

Disclosures

Dr. Shaker has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Yield of Repeat Endoscopy for Barrett's Esophagus After a Normal Index Endoscopy
  2. Esophageal Hypervigilance and Visceral Anxiety Contribute to the Symptom Severity of Laryngopharyngeal Reflux
  3. Association of BMI With Treatment Response to Topical Steroids in Patients With Eosinophilic Esophagitis
  4. Predictors of Histologic Response to Dietary Therapy in Eosinophilic Oesophagitis
  5. Houston-BEST: a Barrett's Esophagus Risk Prediction Model Adaptable to Electronic Health Records
  6. Salivary Microbiota Composition to Discriminate Between Patients With and Without Eosinophilic Oesophagitis
  7. Opioid Exposure Differentially Impacts Esophageal Body Contraction Over the Lower Esophageal Sphincter
  8. Functional Lumen Imaging Probe vs High-Resolution Manometry to Assess Response After POEM
  9. Esophageal Hypervigilance and Symptom-Specific Anxiety in Patients With Eosinophilic Esophagitis
  10. Clinical Significance of Recurrent Gastroesophageal Junction Intestinal Metaplasia After Eradication of Barrett's Esophagus

Most Read This Week

Recently Updated